-
Providers might need to seek other long-acting reversible contraceptive methods other than the new smaller levonorgestrel intrauterine device, Skyla.
-
Long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and the contraceptive implant, can help young women achieve their goals.
-
Results of a trial conducted by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health indicate two new antibiotic regimens.
-
-
NSAIDs and cardiovascular risk; new antithrombotic guidelines; warfarin during surgery; Pfizer selling Viagra online; azithromycin and cardiovascular risk; and FDA actions.
-
A new study shows that the vast majority of low-lying placentas or marginal previas noted in second trimester patients resolved by term. However, there was a doubling of the rate of postpartum hemorrhage in these patients even if the placentas had migrated away from the cervix.
-
-
In 2006, the CDC recommended routine, voluntary HIV testing for persons aged 13-64 in all health care settings, with elimination of separate informed consent5 and this recommendation has basically now been adopted by the U.S. Preventive Services Task Force.
-
As MMR vaccination coverage among mothers increases, compared to mothers with natural immunity the levels of maternal antibodies in offspring at birth decreases and the projected duration of the protection afforded by maternal antibodies among their infants also decreases.
-
In a large population-based retrospective cohort study, adults > 65 years on statin therapy who received a co-prescription for clarithromycin or erythromycin had an elevated risk for developing statin toxicity. There was no associated risk seen with azithromycin.